Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remimazolam Versus Propofol, in Combination With Esketamine for Painless Abortion

NCT05635955 is registered in ClinicalTrials.gov with Maternal and Child Health Hospital of Hubei Province as lead sponsor.

NCT NCT05635955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05635955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remimazolam Versus Propofol, in Combination With Esketamine for Painless Abortion
Lead sponsor
Maternal and Child Health Hospital of Hubei Province
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2022
Completion date
September 30, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion early, anesthesia